# Susan M. Domchek

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/susan-m-domchek/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50,695 |
| Field | BRCA gene mutations in cancer |
| h-index | 105 |
| i10-index | 398 |
| Last Known Institution | University City Science Center |
| OpenAlex ID | https://openalex.org/A5063299870 |
| ORCID iD | https://orcid.org/0000-0002-5914-7272 |
| Works | 1,067 |

## Researcher papers

- [Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer](https://scholariq.org/papers/adjuvant-olaparib-for-patients-with-i-brca1-i-or-i-brca2-i-mutated-breast-cancer/)
- [Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation](https://scholariq.org/papers/olaparib-monotherapy-in-patients-with-advanced-cancer-and-a-germline-i-brca1-2-i/)
- [Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/genetic-familial-high-risk-assessment-breast-ovarian-and-pancreatic-version-2/)
- [A Population-Based Study of Genes Previously Implicated in Breast Cancer](https://scholariq.org/papers/a-population-based-study-of-genes-previously-implicated-in-breast-cancer/)
- [Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)](https://scholariq.org/papers/pathology-of-breast-and-ovarian-cancers-among-i-brca1-i-and-i-brca2-i-mutation/)
- [Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses](https://scholariq.org/papers/genome-wide-association-study-identifies-32-novel-breast-cancer-susceptibility/)
- [NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-genetic-familial-high-risk-assessment-breast-ovarian/)
- [Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer](https://scholariq.org/papers/association-of-type-and-location-of-i-brca1-i-and-i-brca2-i-mutations-with-risk/)
- [Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study](https://scholariq.org/papers/targeted-prostate-cancer-screening-in-brca1-and-brca2-mutation-carriers-results/)
- [Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers](https://scholariq.org/papers/interim-results-from-the-impact-study-evidence-for-prostate-specific-antigen/)
- [A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Carcinoma or Other Solid Tumors](https://scholariq.org/papers/a-phase-i-ii-study-of-the-oral-parp-inhibitor-rucaparib-in-patients-with/)

## Researcher topics

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Nutrition, Genetics, and Disease](https://scholariq.org/topics/nutrition-genetics-and-disease/)

## Researcher university

- [University City Science Center](https://scholariq.org/institutions/university-city-science-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.